ヒト由来試料

臨床検査一覧

米国のCLIA/CAP認定施設にて実施している主要な臨床検査約300種類の一覧です。お探しの検査の記載がない場合は、ご連絡ください。

検査名 検体 技術 疾患 用途
17-OH Progesterone Blood LC-MS/MS Congenital adrenal hyperplasia Diagnosis, treatment selection
Adipophilin FFPE tissue IHC Cutaneous lesions Diagnosis
AFB (Acid Fast Bacteria) Body fluids Culture/dye staining Tuberculosis Diagnosis
ALK D5F3 FFPE tissue IHC NSCLC, inflammatory myofibroblastic tumor Treatment selection
ALK1 FFPE tissue IHC NSCLC, inflammatory myofibroblastic tumor Diagnosis
Alpha-1 Antitrypsin (A1AT) Serum Immunoassay COPD Diagnosis
Amyloid (Congo Red) FFPE tissue IHC Amyloidosis Diagnosis
Androgen Receptor (AR) FFPE tissue IHC Prostate cancer Treatment selection
Angiotensin-Converting Enzyme (ACE) Serum Enzymatic Sarcoidosis, others Diagnosis
APOE Genotype Blood PCR Alzheimer’s Disease, Type III hyperlipoproteinemia Prognosis
Apolipoprotein A1 (ApoA1) Serum Immunoassay Cardiovascular disease Prognosis
Apolipoprotein B (ApoB) Serum Immunoassay Cardiovascular disease Prognosis
Aquaporin 4 Serum Cell culture/FACS Neuromyelitis optica, autoimmune AQP4 channelopathy Diagnosis
Arginase-1 FFPE tissue IHC Hepatocellular carcinoma Diagnosis
B Cell Gene Rearrangement / clonality Body fluids PCR/GE Lymphoproliferative diseases Diagnosis
B. parapertussis Nasopharyngeal aspirate, serum PCR Bordetella parapertussis infection Diagnosis
B. pertussis Serum PCR Bordetella pertussis infection Diagnosis
Babesia Species Blood PCR Babesiosis Diagnosis
Basal Cell Cocktail FFPE tissue IHC Benign and malignant prostatic lesions Diagnosis
Bcl1/Cyclin D1 FFPE tissue IHC Lymphoproliferative diseases Diagnosis
Bcl2 FFPE tissue IHC Lymphoma Diagnosis
Bcl6 FFPE tissue IHC Lymphoma Diagnosis
BCR/ABL1 Mutation Analysis Blood, BM PCR Leukemias Treatment selection
Beta Catenin FFPE tissue IHC Pancreatic, liver, lung and some small soft-tissue cancers Diagnosis
BKV (BK Virus) Plasma PCR Nephropathy in renal transplant recipients Diagnosis / Prognosis
BRAF Tissue PCR Melanoma Treatment selection
BRCA 1/2 Blood NGS Breast cancer, ovarian cancer Prognosis
C. albicans Blood, bodily fluids ELISA, PCR Candidiasis Diagnosis
C. difficile Feces PCR Clostridium difficile infection Diagnosis
Calcitonin Serum Immunoassay Medullary thyroid carcinoma Diagnosis / Monitoring
Calponin FFPE tissue IHC Breast carcinoma Diagnosis
Calprotectin Fecal ELISA Inflammatory bowel disease Diagnosis
CALR Exon 9 Mutations Blood, BM PCR Myeloproliferative neoplasm Diagnosis
Calretinin FFPE tissue IHC Mesotheliomas Diagnosis
Cancer Antigen 125 (CA125) Blood Immunoassay Ovarian cancer Diagnosis / Monitoring
Carbohydrate Antigen 19-9 (CA19-9) Serum Immunoassay Pancreatic cancer Diagnosis / Monitoring
CD 1a FFPE tissue IHC Lymphoblastic leukemia/lymphoma of T-cell lineage Diagnosis
CD10 FFPE tissue IHC Leukemias and lymphomas Diagnosis
CD117 (KIT) FFPE tissue IHC Gastrointestinal stromal tumors Diagnosis
CD138 FFPE tissue IHC Plasma cell neoplasms Diagnosis
CD15 FFPE tissue IHC Leukemias and lymphomas Diagnosis
CD163 FFPE tissue IHC Diseases with macrophage/monocyte involvement Diagnosis
CD176 FFPE tissue IHC Various tumors Diagnosis
CD2 FFPE tissue IHC T-cell lymphoma Diagnosis
CD20 Blood Flow cytometery Immunodeficiencies Diagnosis
CD21 FFPE tissue IHC Follicular dendritic cell sarcoma Diagnosis
CD23 FFPE tissue IHC Low-grade B-cell lymphomas Diagnosis
CD3 Blood Flow cytometery T cell neoplasms Diagnosis
CD30 FFPE tissue IHC A variety of CD30+ neoplasms Prognosis
CD31 FFPE tissue IHC Endothelial neoplasms / angiogenesis Prognosis
CD34 FFPE tissue IHC Various tumors Prognosis
CD38 FFPE tissue IHC Lymphoproliferative and plasma cell proliferative disorders Diagnosis
CD4 Blood Flow cytometery Immunodeficiency Monitoring
CD43 FFPE tissue IHC T-cell lymphomas Diagnosis
CD44 FFPE tissue IHC Various tumors Prognostic
CD45 FFPE tissue IHC Leukemia/lymphoma Diagnosis
CD45RO Blood Flow cytometery Immunodeficiency Monitoring
CD5 FFPE tissue IHC B-cell lymphomas Diagnosis
CD56 FFPE tissue IHC Tumors with neuroendocrine differentiation Diagnosis
CD57 FFPE tissue IHC Tumors of neuroectodermal origin Diagnosis
CD63 Blood Flow cytometery Chronic urticaria Prognosis
CD68 (KP1) FFPE tissue IHC Hematolymphoid neoplasms Diagnosis
CD7 FFPE tissue IHC T-cell lymphoma Diagnosis
CD79A FFPE tissue IHC Leukemias and lymphomas Diagnosis
CD8 Blood Flow cytometery Therapeutic immunosuppression Monitoring
CD99 FFPE tissue IHC Ewing sarcoma, neuroectodermal tumors Diagnosis
CDX2 FFPE tissue IHC Carcinomas of intestinal origin Diagnosis
CEA Serum Immunoassay Colorectal cancer and other tumors Monitoring
CEBPA Mutation Blood, BM Sequencing Acute myeloid leukemia (AML) Diagnosis, prognosis
Celiac Genotype Blood PCR/Luminex Celiac disease Prognosis
Cervical DNA-Dtex (3q26, 5p15) Cervical material FISH Cervical cancer Prognosis
CFTR Blood NGS Cystic fibrosis Treatment selection
CH50 (Complement) Serum Liposome method Complement abnormalities Diagnosis
Chlamydia Various PCR/Chemiluminescence Chlamydia trachomatis infection Diagnosis
Chromogranin A (CGAK) Serum Immunoassay Carcinoid tumors, neuroendocrine tumors, prostate cancer Diagnosis, prognosis, monitoring
CK- (OSCAR) FFPE tissue IHC Carcinomas of unknown origin Diagnosis
CK- AE1/AE3 FFPE tissue IHC Poorly differentiated malignant tumors Diagnosis
CK HMW (34betaE12) FFPE tissue IHC Prostate cancer Diagnosis
CK-19 FFPE tissue IHC Carcinomas with ductal or glandular differentiation Diagnosis
CK-20 FFPE tissue IHC Carcinomas of unknown origin Diagnosis
CK-5/6 FFPE tissue IHC Squamous cell carcinoma and adenocarcinoma, atypical proliferations of the breast Diagnosis
CK-7 FFPE tissue IHC Prostate cancer, carcinoma, sarcomas, primary biliary cirrhosis Diagnosis, prognosis
CK-8 FFPE tissue IHC Epithelial cancer, Anaplastic thyroid carcinoma Diagnosis
CK-8 & 18 FFPE tissue IHC Carcinoma, adenocarcinoma Diagnosis, prognosis
CK-AE1/AE3 FFPE tissue IHC Poorly differentiated malignant tumors Diagnosis
CK-CAM 5.2 FFPE tissue IHC Rectal carcinoma, stomach carcinoma, esophageal carcinoma, bile duct carcinoma, metastatic carcinoma, glioblastoma multiforme, uterine tumors, Paget’s disease, pagetoid squamous cell carcinoma Diagnosis, prognosis, monitoring
CMV (Cytomegalovirus) Body fluids PCR Cytomegalovirus infection Diagnosis
CMV (Cytomegalovirus) Antibody Serum Immunoassay Cytomegalovirus infection Diagnosis
Common Acute Lymphocytic Leukemia Antigen (CD 10) FFPE tissue IHC Acute lymphocytic leukemia, Burkitt lymphoma, follicular germinal center lymphoma Diagnosis
Complement 3 (C3) Serum Turbidity Systemic lupus erythematosus and others Diagnosis / Monitoring
Copper Stain FFPE tissue Chemical Wilson’s disease Diagnosis
Covid-19 Antibody Nasal or throat swab PCR Covid-19 infection Diagnosis
Covid-19 Nucleic acid Nasal or throat swab Immunoassay Covid-19 infection Diagnosis / Monitoring
Crystal Violet Amyloid FFPE tissue Chemical Amyloidosis Diagnosis
C-Telopeptide Serum Immunoassay Osteoporosis, Paget’s disease (bone resorption marker), osteopenia Monitoring
Cyclin D1 FFPE tissue IHC Low-grade B-cell lymphomas Diagnosis
CYP2C19 Genotype Blood, saliva PCR Altered metabolism of drugs Treatment selection
CYP2D6 Blood, saliva PCR Altered metabolism of drugs Treatment selection
CYP450 2C9-VKORC1 Blood, saliva PCR Altered metabolism of warfarin (Coumadin), cardiovascular disease Treatment selection
Cystic Fibrosis 139 Blood, others PCR/Luminex Cystic fibrosis Diagnosis
Cystic Fibrosis 39 Blood, others PCR/Luminex Cystic fibrosis Diagnosis
Desmin FFPE tissue IHC Leiomyosarcomas, rhabdomyosarcomas Diagnosis
DHEA Serum LC/MS Hyperandrogenism, congenital adrenal hyperplasia (CAH), premature adrenarche Diagnosis
DHTS (Dihydrotestosterone) Serum LC/MS Prostate disease, benign prostatic hyperplasia Monitoring
DOG-1 FFPE tissue IHC Gastrointestinal stromal tumors (GISTs) Diagnosis
EBV (Epstein-Barr Virus) Antibody Serum Immunoassay Epstein-Barr virus infection Diagnosis
Ecadherin FFPE tissue IHC Breast cancer Diagnosis
EGFR 29 Mutation Panel FFPE tissue PCR Non-small cell lung cancers (NSCLCs) Treatment selection
Elastic Stain FFPE tissue Chemical Elastic tissue disorders, alopecia, inflammatory skin disorders and neoplastic proliferations. Diagnosis
EMA Serum Immunoassay Dermatitis herpetiformis, celiac disease Diagnosis, monitoring
Ep-CAM (BER-Ep4) FFPE tissue IHC Basal cell carcinoma of the skin, squamous cell carcinoma of the skin, pulmonary adenocarcinoma, pulmonary mesothelioma Diagnosis
Epi proColon Plasma PCR Colorectal cancer (CRC) Diagnosis
ER FFPE tissue IHC breast, cervix, endometrium, uterus, ovary, and prostate cancer Diagnosis, treatment selection
ERG FFPE tissue IHC Prostate cancer Diagnosis
Estradiol Serum LC-MS/MS Hypogonadism, oligo-amenorrhea, hypogonadal premenopausia, feminization, gynecomastia, disorders of sex steroid metabolism, adrenal tumors Diagnosis, monitoring
Estrogens Fractionated Serum LC-MS/MS Precocious and delayed puberty, disorders of sex steroid metabolism, hypogonadism, oligo-amenorrhea, menopause, andropause, feminization, gynecomastia, estrogen-producing neoplasms Diagnosis, prognosis, monitoring, treatment selection
Estrone Serum LC-MS/MS Precocious and delayed puberty, disorders of sex steroid metabolism, osteoporosis Diagnosis, monitoring
Factor 13A FFPE tissue IHC Acquired digital fibrokeratomas, angiofibromas, oral fibroma, histiocytomas Diagnosis
Factor V Leiden Blood PCR Thrombophilia Diagnosis
Factor VIII Activity Plasma APTT Hemophilia A, von Willebrand disease, Diagnosis, monitoring
Fibrinogen Plasma Immunoprecipitation Afibrinogenemia, hypofibrinogenemia, dysfibrinogenemias, chronic hepatitis, hepatoma, advanced liver disease, renal diseases, chronic glomerulonephritis, hypernephroma Diagnosis, monitoring
Fragile X Various PCR Fragile X syndrome, fragile X tremor/ataxia syndrome, premature ovarian insufficiency Diagnosis
Fusion Transcripts FFPE tissue NGS Cancer, soft tissue and bone tumors, Diagnosis, prognosis, treatment selection
GAD65 Antibody Serum Immunoprecipitation Type 1 and type 2 diabetes, autoimmune (type 1, insulin-dependent) diabetes, endocrine disorders, thyroiditis, pernicious anemia, stiff-man syndrome, autoimmune encephalitis, cerebellitis, brain stem encephalitis, myelitis, organ-specific neurological disorders, myasthenia gravis, Lambert-Eaton syndrome Diagnosis, prognosis
Galectin-3 (9C4) Serum ELISA Benign and malignant thyroid neoplasms , anaplastic large cell lymphoma. Diagnosis
Gastric Parietal Cell Antibody Serum ELISA Pernicious anemia, atrophic gastritis, diabetes, gastric ulcer, thyroid disease Diagnosis
Gastrin Serum Immunoassay Achlorhydria, pernicious anemia, Zollinger-Ellison syndrome, gastrinoma Diagnosis
GATA3 FFPE tissue IHC Carcinomas, including primary bladder and breast carcinomas, and some types of mesenchymal and neuroectodermal tumors Diagnosis
GCDFP-15 FFPE tissue IHC Extramammary Paget disease, carcinomas of the salivary glands, sweat glands, and prostate Diagnosis
GFAP FFPE tissue IHC Glial tumors Diagnosis
GLUT-1 FFPE tissue IHC Carcinomas, fallopian tube carcinomas Diagnosis
Glycophorin A FFPE tissue IHC Chronic myelogenous leukemia, erythroid hypoplasia Diagnosis
Glypican-3 FFPE tissue IHC Hepatocellular carcinomas, hepatic adenomas Diagnosis
GMS stain Lung aspirates, others IHC Infectious pulmonic disease. Pneumocystis carinii and fungal organisms infections Diagnosis
Gram Stain Various Chemical Bacterial or fungal infection  
Granzyme B FFPE tissue IHC Lymphomas Diagnosis
Group B Streptococcus Various Culture/various Group B Streptococcus infection Diagnosis
H. Pylori Breath RI/Spectrophotometry Helicobacter Pylori infection Diagnosis, monitoring
HBME-1 FFPE tissue IHC Thyroid carcinomas Diagnosis
HCV (Hepatitis C Virus) Serum PCR Hepatitis C virus infection Diagnosis, monitoring
HCV (Hepatitis C Virus) Antibody Serum Immunoassay Hepatitis C virus infection Diagnosis, monitoring
Hemochromatosis Gene Blood PCR Hereditary hemochromatosis (HH), Diagnosis, prognosis
Her2/neu FFPE tissue IHC Human breast, endometrial, ovarian, and other epithelial cancers, ductal carcinoma, solid/intracystic papillary carcinoma Prognosis, treatment selection
Her2/neu Amplification FFPE tissue FISH Breast carcinoma Prognosis, treatment selection
HHV-6 (Human Herpesvirus 6) Plasma PCR HHV-6 infection Diagnosis
HHV-8 (Human Herpesvirus 8) FFPE tissue IHC HHV-8 infection Diagnosis
HHV-8 (Human Herpesvirus 8) Serum, plasma PCR HHV-8 infection Diagnosis
HIV (Human Immunodeficiency Virus) Serum Immunoassay HIV infection Diagnosis, monitoring
HLA-B1502 Saliva PCR Epilepsy, trigeminal neuralgia, bipolar disorder Treatment selection
HLA-B27 Blood Immunoassay Ankylosing spondylitis, juvenile rheumatoid arthritis, Reiter syndrome Diagnosis
HLA-B5701 Blood, others PCR Human immunodeficiency virus (HIV) infection, renal cell carcinoma, soft tissue sarcoma Treatment selection
HLA-B5801 Blood PCR Gout or gouty arthritis, high uric acid levels, nephrolithiasis , cancer Treatment selection
HMB-45 FFPE tissue IHC Melanoma, benign nevi, tumors Diagnosis
HPV (Human Papillomavirus) Cervical specimens PCR HPV-16 and/or HPV-18 infection, cervical cancer Diagnosis, prognosis
HSA (Hep-Par) FFPE tissue IHC Hepatocellular carcinoma Diagnosis
HSV (Herpes Simplex Virus) Serum Immunoassay HSV infection Diagnosis, monitoring
HSV-2 (Herpes Simplex Virus) Various PCR   Diagnosis, monitoring
Human Epididymis PRO4 Serum Immunoassay Epithelial ovarian cancer Monitoring
IgA Serum Immunoassay IgA monoclonal gammopathies and IgA-related immune deficiencies, hepatic disease, hepatitis, liver cirrhosis, connective tissue diseases, acute and chronic infections Diagnosis, monitoring
IgG Serum Immunoassay IgG monoclonal gammopathies and immune deficiencies, hepatic disease, hepatitis, liver cirrhosis, connective tissue diseases, acute and chronic infections, neonates with intrauterine and perinatal infections, multiple myeloma, primary systemic amyloidosis, monoclonal gammopathy of undetermined significance Diagnosis, monitoring
IgM Serum Immunoassay IgM monoclonal gammopathies and IgM-related immune deficiencies, hepatic disease, hepatitis, liver cirrhosis, connective tissue diseases, acute and chronic infections, neonates with intrauterine and perinatal infections, macroglobulinemia, primary systemic amyloidosis, monoclonal gammopathy of undetermined significance Diagnosis, monitoring
Inhibin Serum Immunoassay granulosa cell tumors, mucinous epithelial ovarian tumors Diagnosis, monitoring
Intrinsic Factor Antibody Serum Immunoassay Pernicious anemia Diagnosis
Iron Hematoxylin Feces IHC Parasitosis Diagnosis
Islet Antigen 2 Antibody Serum Immunoprecipitation Type 1 and type 2 diabetes mellitus Diagnosis, prognosis
JAK2 Non-V617F Mutations Blood PCR Polycythemia vera (PV), myeloproliferative neoplasms, thrombocytosis and myelofibrosis Diagnosis
JAK2 V617F Mutation Blood, BM PCR Polycythemia vera (PV), myeloproliferative neoplasms, thrombocytosis and myelofibrosis  
JC Virus (Human polyomavirus 2) CSF PCR JC Virus infection, progressive multifocal leukoencephalopathy Diagnosis, monitoring
JC Virus (Human polyomavirus 2) CSF ISH JC Virus infection, progressive multifocal leukoencephalopathy Diagnosis, monitoring
KAPPA Serum Electrophoresis Lymphoproliferative disorders, B-cell lymphomas/leukemias. Diagnosis
Ki-67 FFPE tissue IHC Neoplasms, malignant lymphomas, prostatic and breast adenocarcinomas, astrocytic neoplasms, and soft tissue neoplasms Diagnosis, prognosis
KRAS Mutation 7-panel FFPE tissue PCR Colorectal cancer Prognosis, treatment selection
Lacosamide Serum LC-MS/MS Severe renal impairment, mild-to-moderate hepatic impairment, and end-stage renal disease, epilepsia Monitoring
Lactoferrin Feces ELISA Inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) Diagnosis
Lambda Serum Immunoassay Multiple myeloma (MM), light chain multiple myeloma (LCMM), Waldenstrom macroglobulinemia (WM), non-secretory myeloma (NSMM), smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), primary systemic amyloidosis (AL), and light chain deposition disease (LCDD) Monitoring
Lambda Serum Immunoassay Plasmacytic neoplasm Diagnosis
Lamotrigine Serum LC-MS/MS Bipolar I disorder, seizure disorders, Lennox-Gastaut syndrome, primary generalized tonic-clonic seizures, and partial seizures, migraine, trigeminal neuralgia, refractory depression Monitoring
LD Isoenzymes Serum Electrophoresis Cardiorespiratory diseases, malignancy, hemolysis, disorders of the liver, kidneys, lung, and muscle Diagnosis
Leder (Chloroacetate Esterase) Blood, FFPE IHC Mast cell disorders, myeloid disorders Diagnosis
Lewis Y FFPE tissue IHC Lung adenocarcinoma, cholangiocarcinoma, hepatocellular carcinoma, breast cancer Diagnosis / Prognosis
Lipoprint Serum plasma Electrophoresis Cardiovascular disease, dyslipoproteinemia, hyperlipoproteinemias, Diagnosis, prognosis, monitoring
LP-PLA2 Activity Serum Enzymatic Coronary heart disease Prognosis
Lupus Anticoagulation Plasma Oher Systemic lupus erythematosus, autoimmune disorders, collagen vascular disease Diagnosis
Luxal Fast Blue FFPE tissue Chemical Pathological processes in the CNS Diagnosis
M. pneumoniae Antibody Serum Immunoassay Mycoplasma pneumoniae infection Diagnoisis
M. pneumoniae Nucliec Acid Various PCR Mycoplasma pneumoniae infection Diagnoisis
Mammaglobin FFPE tissue IHC Human breast cancer, tumors of unknown primary site Diagnosis
Mast Cell Tryptase Serum Immunoassay Systemic mastocytosis, mast cell activation syndrome, Anaphylaxis, allergen challenge Diagnosis
Melan-A (MART-1) FFPE tissue IHC Melanoma, clear cell sarcoma, melanotic neurofibroma, melanotic schwannoma, perivascular epithelioid cell tumor Diagnosis
Melanin Bleach FFPE tissue Chemical Melanoma, Acral lentiginous melanoma Diagnosis
Melanoma Associated Antigen FFPE tissue IHC Melanoma Diagnosis
Methylmalonic Acid Serum LC-MS/MS Methylmalonic acidemia, cobalamin (vitamin B12) deficiency Diagnosis, monitoring
Microsatellite Instability (MSI) FFPE tissue PCR Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome, colorectal, endometrial cancer. gastric cancer, ovarian cancer, hepatobiliary and urinary tract carcinomas, small bowel cancer Diagnosis, prognosis
MITF FFPE tissue IHC Melanoma Diagnosis
MLH-1 Blood, others Sequencing Constitutional mismatch repair deficiency (CMMRD) / Lynch syndrome, ovarian cancer Diagnosis, prognosis
MLH-1 Promoter Hypermethylation FFPE tissue PCR Hereditary nonpolyposis colon cancer (HNPCC), / Lynch syndrome, Diagnosis, prognosis
MOC-31 FFPE tissue IHC Tumors of epithelial origin, adenocarcinomas, papillary serous carcinoma, breast, lung, prostate, and cholangiocarcinoma, among others Diagnosis
MPL Codon 515 Mutation Blood, BM Sequencing Myeloproliferative neoplasms (MPNs), polycythaemia vera, essential thrombocythaemia, or primary myelofibrosis Diagnosis
MSH-2 FFPE tissue IHC Hereditary nonpolyposis colon cancer/Lynch syndrome Prognosis
MSH-6 Blood, others Sequencing Hereditary nonpolyposis colon cancer/Lynch syndrome. hereditary endometrial carcinoma Prognosis
MTHFR Mutation Det Blood Nucleic acid-based Coronary artery disease, acute myocardial infarction, peripheral vascular artery disease, stroke, or venous thromboembolism Diagnosis, prognosis
MUM-1 FFPE tissue IHC Hematolymphoid neoplasms, melanomas Diagnosis
Myeloperoxidase Antibody Serum Immunoassay Immune-mediated vasculitis, microscopic polyangiitis (MPA) Diagnosis, monitoring
Myoglobin Serum Immunoassay Muscle damage Diagnosis
N. gonorrhoeae Various PCR Neisseria gonorrhoeae infection Diagnosis
Napsin A FFPE tissue IHC Carcinomas, lymphomas, primary lung adenocarcinoma Diagnosis
Neurofilament FFPE tissue IHC Neoplastic cells of neural origin , neuromas, gangliogliomas, neuroblastomas, medulloblastomas, pheochromocytoma, chemodectomas, and carcinoid tumors Diagnosis
NGF Various Sequencing Neuropathy, hereditary sensory and autonomic Diagnosis
NKX3.1 FFPE tissue IHC Prostate cancer, metatstatic adenocarcinoma, prostatic origin tumors Diagnosis
NRAS BRAF EGFR Mutations FFPE tissue PCR Lung cancer Diagnosis, prognosis, treatment selection
NSE Serum Immunoassay Neuron-specific enolase-secreting tumors, small cell lung carcinoma, carcinoids, islet cell tumors and neuroblastomas, comatose patients Diagnosis, monitoring
N-Telopeptide Urine Immunoassay Osteopenia, osteoporosis, conditions associated with increased bone turnover Diagnosis, monitoring
Oncotype DX FFPE tissue PCR Breast cancer Prognosis, treatment selection
Osteocalcin Serum Immunoassay Osteopenia, osteoporosis, Paget’s disease, disorders in which osteocalcin levels are elevated, cancer accompanied by bone metastases, primary hyperparathyroidism, renal osteodystrophy Diagnosis, monitoring
p120 Catenin FFPE tissue IHC Desmoid-type fibromatosis Diagnosis
P16 FFPE tissue IHC Human papilloma virus infection Diagnosis
p40 FFPE tissue IHC Carcinomas, squamous cell carcinoma, lymphomas Diagnosis
P504S (AMACR) FFPE tissue IHC High-grade prostatic intraepithelial neoplasia, prostate cancer Diagnosis
P53 FFPE tissue IHC Cancer, colon, stomach, bladder, breast, lung, and testes cancers, melanoma, lymphoma. Diagnosis, prognosis
p57 FFPE tissue IHC Hydatidiform Mole, Wilm’s tumor, Beckwith Wiedemann syndrome (BWS), sporadic cancers Diagnosis
P63 FFPE tissue IHC Squamous, urothelial, myoepithelial, tumors Diagnosis
PAI-1 Genotype Blood PCR Cardiovascular disease, Chronic venous insufficiency (CVI) Prognosis
Pancreatic Elastase 1 Feces ELISA Pancreatic Insufficiency Diagnosis, monitoring
Pax5 FFPE tissue IHC Lymphomas Diagnosis
Pax8 FFPE tissue IHC Renal cell carcinomas, ovarian carcinoma, papillary thyroid carcinomas, tumors of Mullerian origin Diagnosis
PD-L1 (22C3) FFPE tissue IHC Carcinomas of the urinary bladder, lung, gastric and gastroesophageal junction, thymus, colon, pancreas, ovary, breast, kidney, melanoma, glioblastoma. Diagnosis, prognosis
PD-L1 (SP142) FFPE tissue IHC Carcinomas of the urinary bladder, lung, thymus, colon, pancreas, ovary, breast, kidney, in melanoma, glioblastoma. Diagnosis, prognosis
PD-L1: (28-8) FFPE tissue IHC Non-squamous non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (SCCHN), urothelial carcinoma (UC), melanoma Prognosis, treatment selection
PD-L1: (SP263) FFPE tissue IHC Carcinomas of the urinary bladder, lung, thymus, colon, pancreas, ovary, breast, kidney, in melanoma, glioblastoma. Diagnosis, prognosis
PGP 9.5 FFPE tissue IHC Small fiber peripheral neuropathy Diagnosis
PHH3 FFPE tissue IHC Breast cancer, breast carcinomas Diagnosis, prognosis
Phosphatidyl Antibody Serum ELISA Antiphospholipid syndrome (APS) Prognosis, treatment selection
PIN-4 (P504S, HMW Cytokeratin, p63) FFPE tissue IHC Prostate cancer, prostatic adenocarcinoma, Diagnosis
PLAP FFPE tissue IHC Germ-cell tumors, adenocarcinomas, tumors of Mullerian derivation, pulmonary and colonic carcinomas, renal cell carcinomas. Diagnosis
PML/RARA Fusion Protein Blood PCR Promyelocytic leukaemia Diagnosis, monitoring
PMS-2 Blood, others Sequencing Lynch syndrome/hereditary nonpolyposis colorectal cancer Diagnosis, prognosis
Podoplanin (D240) FFPE tissue IHC Follicular dendritic cells sarcoma, mesothelioma, seminoma, epithelioid malignant mesothelioma Diagnosis
PR FFPE tissue IHC Breast cancer Prognosis, treatment selection
PRO(P504S/KER903) FFPE tissue IHC Prostate cancer Diagnosis
Prothrombin G20210A Mutation Blood PCR Thrombophilia Diagnosis
PSA Serum Immunoassay Benign prostatic hypertrophy, prostatitis, prostate cancer Diagnosis, monitoring
PSAP FFPE tissue IHC Prostate adenocarcinoma and urothelial carcinoma Diagnosis
PTAH FFPE tissue Chemical Tumours of skeletal muscles, ependymomas Diagnosis
PTEN Blood, others Sequencing PTEN hamartoma tumor syndrome, Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, Proteus-like syndrome Diagnosis
Reticulin Stain FFPE tissue Chemical Liver pathologies Diagnosis
RF IgA IgG IgM Serum Immunoassay Rheumatoid Arthritis, Henoch Schoenlein purpura, hepatitis C, Sjogren Syndrome Diagnosis
Rickettsia Species Antibody Serum ELISA Rickettsia species infections Diagnosis
Rickettsia Species Nucleic Acid Blood PCR Rickettsia species infections Diagnosis
S 100 FFPE tissue IHC Cartilaginous tumors, myoepithelial tumors, Schwann cells and neural tumors, Langerhans cell proliferations, benign and malignant melanocytes, clear cell sarcoma, and some carcinomas (particularly of the breast) Diagnosis
S. cerevisiae Serum Immunoassay Saccharomyces cerevisiae infection, baker’s yeast allegy Diagnosis
Sex Hormone-Binding Globulin (SHBG) Serum Immunoassay Androgen excess, polycystic ovarian syndrome, idiopathic hirsutism. disorders of puberty, anorexia nervosa, thyrotoxicosis, insulin resistance, type 2 diabetes, cardiovascular disease Diagnosis, monitoring
SMA (Smooth Muscle Actin) Serum Immunoassay Chronic liver disease, primary biliary cirrhosis, chronic viral hepatitis, alcoholic chronic hepatitis Diagnosis
SMA (Spinal muscular atrophy) Blood, others PCR Spinal muscular atrophy (SMA) Diagnosis, prognosis, treatment selection
SMM (Smooth Muscle Myosin) FFPE tissue IHC Benign sclerosing breast lesions, infiltrating carcinomas Diagnosis
Smoothelin FFPE tissue IHC Transurethral resection of urinary bladder tumor (TURBT), urothelial carcinoma, bladder carcinoma Diagnosis
Solid Tumor Panel FFPE tissue NGS Cancer, solid tumors Diagnosis, prognosis, treatment selection
SOX10 FFPE tissue IHC Malignant peripheral nerve sheath tumor, synovial sarcoma, intraneural synovial sarcoma, malignant melanoma, Schwannomas, neurofibromas. Diagnosis
Stromelysin-3 FFPE tissue IHC Meningiomas, invasive breast cancer, Rheumatoid Arthritis Diagnosis, prognosis, monitoring
Synaptophysin FFPE tissue IHC Neuronal tumors and tumors with neuroendocrine differentiation, neuroblastoma, ganglioneuroblastoma, ganglioneuroma, pheochromocytoma/paraganglioma, carcinoid/neuroendocrine carcinoma Diagnosis
T Cell Gene Rearrangement BM PCR/GE T cell lymphoma Diagnosis
T. Pallidum Antibody Serum Immunoassay Syphilis Diagnosis
TdT FFPE tissue IHC Leukemias, lymphomas Diagnosis
Testosterone Female Serum LC/MS/MS Abnormal testosterone levels,infertility, polycystic ovary syndrome (PCOS) Diagnosis, monitoring
Testosterone Male Serum LC/MS/MS Abnormal testosterone levels,erectile dysfunction Diagnosis, monitoring
TFE3 Mutation FFPE tissue FISH Renal cell carcinoma. alveolar soft-part sarcoma Diagnosis
Thyroglobulin Serum Immunoassay, LC/MS/MS Disordered thyroid growth, goiter, thyroiditis, thyroid cancer Diagnosis, monitoring
Toluidine Blue FFPE tissue Chemical Oropharyngeal carcinomas Prognosis
Topiramate Serum LC/MS/MS Epilepsy, seizures, Lennox-Gastaut syndrome, migraine Monitoring
Total Bile Acids Serum Enzymatic Liver disease, chronic hepatitis C, intrahepatic cholestasis of pregnancy Diagnosis, monitoring
Tpmt Genotype Blood, others PCR Acute lymphoblastic leukemia, autoimmune disorders, Crohn disease, rheumatoid arthritis, organ transplant recipients Prognosis, treatment selection
Trichomonas Urine, others Nucleic acid-based Trichomoniasis Diagnosis
Triiodothyronine Serum Immunoassay Hyperthyroidism, euthyroid patients who have an altered distribution of binding proteins Diagnosis, monitoring
TSH Receptor Antibody Serum Immunoassay Thyrotoxicosis, endocrine exophthalmos, pretibial myxedema, thyroid acropachy Diagnosis, prognosis
TTF-1 FFPE tissue IHC Carcinomas of unknown origin, squamous cell carcinoma Diagnosis
Tyrosinase FFPE tissue IHC Malignant melanoma Diagnosis
Ureaplasma Plasma PCR Ureaplasma Diagnosis, monitoring
Uric Acid Stain Urine, FFPE tissue Chemical Nephropathy Diagnosis
Villin FFPE tissue IHC Metastatic carcinomas of intestinal origin, renal cell carcinoma, bladder carcinoma, ovarian mucinous carcinomas Diagnosis
Von Kossa Stain FFPE tissue Chemical Calcinosis Diagnosis
Von Willebrand Panel Blood, others NGS Von Willebrand Disease (VWD), Diagnosis, monitoring
VZV (Varicella-Zoster Virus) FFPE tissue IHC Varicella-zoster virus (VZV) infection Diagnosis
Warthin-Starry Stain FFPE tissue IHC Spirochetes, H. pylori and microsperediate infection Diagnosis
WNV (West Nile Virus) Antibody Serum Immunoassay West Nile virus infection Diagnosis
WNV (West Nile Virus) Nucleic acid Plasma PCR West Nile virus infection Diagnosis
Wt-1 FFPE tissue IHC Wilms tumor Diagnosis
Zika Virus Antibody Serum Immunoassay Zika virus infection Diagnosis
Zika Virus Nucleic acid Serum PCR Zika virus infection Diagnosis
Zinc Transporter 8 Antibody Serum Immunoassay Type 1 diabetes mellitus (DM) Diagnosis, prognosis